Your contact person
Manager PR & Communications Jan Phillip Denkers
tiakis: Treatment of COVID-19
tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...
Read more …
Natural substances show promise against coronavirus
Three natural compounds present in foods like green tea, olive oil and red wine are promising candidates for the development of drugs against the coronavirus. ...
Read more …
Evotec: € 7.5 m grant for development of COVID-19 therapeutic
Evotec SE announced that the Company has been selected by the German Federal Ministry of Education and Research (“BMBF”) to receive a grant for the ...
Read more …
Why are alpha and delta faster than wild type?
How do virus variants arise and how do they spread? This is one of the key questions of a new research project initiated jointly by ...
Read more …
Sysmex supports healthcare workers in fighting the pandemic
Sysmex Europe GmbH announces the launch of the HISCL™-5000 fully automated random-access immunochemistry analyser and the HISCL™ SARS-CoV-2 Ag Assay Kit ...
Read more …
Start of COVID-19 vaccine production in Reinbek
Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, was joined today by Federal Minister of Health Jens Spahn, Minister
Read more …
DESY X-ray lightsource identifies candidates for COVID
A team of researchers has identified several candidates for drugs against the coronavirus SARS-CoV-2 at DESY´s high-brilliance X-ray lightsource PETRA III. They bind to an ...
Read more …
Testing power
Detecting traces of SARS-CoV-2 by PCR or antibody test has become the linchpin in the fight against the coronavirus pandemic. The diagnostics specialists from the ...
Read more …
Transport patients with infectious diseases
How can healthcare professionals safely transport people with infectious diseases such as COVID-19 or highly pathogenic pathogens such as Ebola? What do you have to ...
Read more …
synthetic mini-antibody to combat COVID-19
By screening hundreds of synthetic mini-antibodies called sybodies, a group of scientists has identified one that might stop SARS-CoV-2 from infecting human cells ...
Read more …
APPLY TO THE OPEN CALL INNO4COV-19
INNO4COV-19 Open Call aims to provide financial support to companies with the goal of accelerating the development and commercialization of innovative solutions that tackle COVID-19 ...
Read more …
Just - Evotec produce antibody products against COVID-19
Evotec SE today announced that the U.S. Department of Defense (“DOD”) awarded its Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to ...
Read more …- 1
- 2